A Technology for the Facilitation of Organ Transplantation: TransVax™

This technology is a treatment for the facilitation of organ transplantation. The immune systems of two persons can be tailored, so that one person can readily receive organs from the other, and vice versa, without the issue of rejection. This treatment is expected to alleviate the need for harmful immunosuppressants, which weaken the entire system. The rights to this technology are protected by Network Immunology’s US provisional patent application #61/429,708.